Increasing Recognition and Emerging Therapies Argue for Dedicated Clinical Trials in Chronic Myelomonocytic Leukemia

Investigators discuss recent therapeutic advances and innovative treatment strategies in chronic myelomonocytic leukemia (CMML), including global and molecularly targeted approaches, and discuss what may help to make progress in the design of rationally derived and disease-modifying therapies for CMML.